The Influence of Tumor Necrosis Factor–α and Interleukin‐10 Gene Promoter Polymorphism on the Inflammatory Response in Experimental Human Endotoxemia
Open Access
- 1 November 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (9), 1601-1603
- https://doi.org/10.1086/323197
Abstract
In this study, we show that there is no correlation between tumor necrosis factor–α gene promoter polymorphism at position -308, interleukin-10 gene promoter polymorphism at position -1082, and the cytokine levels they produce in the human endotoxemia model.Keywords
This publication has 11 references indexed in Scilit:
- Are differences in interleukin 10 production associated with joint damage?Rheumatology, 2000
- Leukocyte activation and cytokine production during experimental human endotoxemiaEuropean Journal of Internal Medicine, 2000
- Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic OptionsThe Journal of Infectious Diseases, 2000
- Interleukin-10 (IL-10) genotypes in inflammatory bowel diseaseTissue Antigens, 1999
- Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and MortalityJAMA, 1999
- Why immunomodulatory therapies have not worked in sepsisIntensive Care Medicine, 1999
- Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humansClinical and Experimental Immunology, 1998
- Genetic influence on cytokine production and fatal meningococcal diseaseThe Lancet, 1997
- Variation in the Tumor Necrosis Factor- Gene Promoter Region May Be Associated with Death from Meningococcal DiseaseThe Journal of Infectious Diseases, 1996
- Secretion of Tumour Necrosis Factor α and Lymphotoxin α in Relation to Polymorphisms in the TNF Genes and HLA‐DR Alleles. Relevance for Inflammatory Bowel DiseaseScandinavian Journal of Immunology, 1996